These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 24861991)
1. Incidence of type 2 diabetes among patients exposed to the combination of pravastatin and paroxetine. Gooden KM; Bibeau KB; Wood J; Irizarry MC; Pan X; Allen J; Sampson T; Heim JM Curr Drug Saf; 2015; 10(2):152-8. PubMed ID: 24861991 [TBL] [Abstract][Full Text] [Related]
2. Increased Risk of Diabetes Among 6-24-Year-Olds Using Second Generation Antipsychotics. Xing S; Lee TA J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):782-791. PubMed ID: 28799787 [TBL] [Abstract][Full Text] [Related]
4. Co-medication of pravastatin and paroxetine-a categorical study. An L; Ravindran PP; Renukunta S; Denduluri S J Clin Pharmacol; 2013 Nov; 53(11):1212-9. PubMed ID: 23907716 [TBL] [Abstract][Full Text] [Related]
5. Atypical antipsychotic initiation and the risk of type II diabetes in children and adolescents. Sohn M; Talbert J; Blumenschein K; Moga DC Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):583-91. PubMed ID: 25808613 [TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
7. Statins and new-onset diabetes: a retrospective longitudinal cohort study. Ma T; Tien L; Fang CL; Liou YS; Jong GP Clin Ther; 2012 Sep; 34(9):1977-83. PubMed ID: 22939164 [TBL] [Abstract][Full Text] [Related]
8. Statin Use and the Risk for Incident Diabetes Mellitus in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Population-Based Retrospective Cohort Study in Taiwan. Lin ZF; Wang CY; Shen LJ; Hsiao FY; Lin Wu FL Can J Diabetes; 2016 Jun; 40(3):264-9. PubMed ID: 26992286 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Glucose Measures in Patients Receiving Concomitant Paroxetine and Pravastatin to Other SSRI/Statin Combinations. Orrico KB; Huynh MH; Olson CW Ann Pharmacother; 2014 Sep; 48(9):1172-1176. PubMed ID: 24928102 [TBL] [Abstract][Full Text] [Related]
10. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis. Koro CE; Sowell MO; Stender M; Qizilbash N Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791 [TBL] [Abstract][Full Text] [Related]
11. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study. Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855 [TBL] [Abstract][Full Text] [Related]
12. Comparative risk of lipophilic and hydrophilic statins on incident depression: A retrospective cohort study. Dave CV; Winterstein AG; Park H; Cook RL; Hartzema AG J Affect Disord; 2018 Oct; 238():542-546. PubMed ID: 29936394 [TBL] [Abstract][Full Text] [Related]
13. Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project. Pfeffer MA; Keech A; Sacks FM; Cobbe SM; Tonkin A; Byington RP; Davis BR; Friedman CP; Braunwald E Circulation; 2002 May; 105(20):2341-6. PubMed ID: 12021218 [TBL] [Abstract][Full Text] [Related]
14. Type II diabetes mellitus and the incidence of amyotrophic lateral sclerosis. Tsai CP; Lee JK; Lee CT J Neurol; 2019 Sep; 266(9):2233-2243. PubMed ID: 31152300 [TBL] [Abstract][Full Text] [Related]
15. Drug usage patterns and treatment costs in newly-diagnosed type 2 diabetes mellitus cases, 2007 vs 2012: findings from a large US healthcare claims database analysis. Weng W; Liang Y; Kimball ES; Hobbs T; Kong S; Sakurada B; Bouchard J J Med Econ; 2016 Jul; 19(7):655-62. PubMed ID: 26855139 [TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials. Carpenter DJ; Fong R; Kraus JE; Davies JT; Moore C; Thase ME J Clin Psychiatry; 2011 Nov; 72(11):1503-14. PubMed ID: 21367354 [TBL] [Abstract][Full Text] [Related]
17. Statin Use, Diabetes Incidence and Overall Mortality in Normoglycemic and Impaired Fasting Glucose Patients. Castro MR; Simon G; Cha SS; Yawn BP; Melton LJ; Caraballo PJ J Gen Intern Med; 2016 May; 31(5):502-8. PubMed ID: 26850412 [TBL] [Abstract][Full Text] [Related]
18. Risk of new-onset diabetes among patients treated with statins according to hypertension and gender: Results from a nationwide health-screening cohort. Lee SE; Sung JM; Cho IJ; Kim HC; Chang HJ PLoS One; 2018; 13(4):e0195459. PubMed ID: 29630642 [TBL] [Abstract][Full Text] [Related]
19. Lipid-lowering drugs and risk of new-onset diabetes: a cohort study using Japanese healthcare data linked to clinical data for health screening. Ooba N; Setoguchi S; Sato T; Kubota K BMJ Open; 2017 Jun; 7(6):e015935. PubMed ID: 28667223 [TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan. Chang CY; Yeh YH; Chan YH; Liu JR; Chang SH; Lee HF; Wu LS; Yen KC; Kuo CT; See LC Cardiovasc Diabetol; 2017 Dec; 16(1):159. PubMed ID: 29258504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]